| 000 | 01426 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515172638.0 | ||
| 264 | 0 | _c20090731 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 024 | 7 |
_a10.5414/cpp47391 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSörgel, F | |
| 245 | 0 | 0 |
_aBiosimilarity of HX575 (human recombinant epoetin alfa) and epoetin beta after multiple subcutaneous administration. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cJun 2009 |
||
| 300 |
_a391-401 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies _xanalysis |
| 650 | 0 | 4 | _aBlood Cell Count |
| 650 | 0 | 4 | _aEpoetin Alfa |
| 650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
| 650 | 0 | 4 | _aHematocrit |
| 650 | 0 | 4 |
_aHemoglobins _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 700 | 1 | _aThyroff-Friesinger, U | |
| 700 | 1 | _aVetter, A | |
| 700 | 1 | _aVens-Cappell, B | |
| 700 | 1 | _aKinzig, M | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 47 _gno. 6 _gp. 391-401 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/cpp47391 _zAvailable from publisher's website |
| 999 |
_c18899154 _d18899154 |
||